AZ Blue Reverses Plan to Drop Two HIV Drugs From 2027 ACA Plans After Questions

Arizona’s largest health insurer sent letters to patients in late October telling them their HIV medications would vanish from 2027 marketplace plans, then reversed course Friday after a local news outlet asked questions.

Blue Cross Blue Shield of Arizona, known as AZ Blue, had planned to drop the preventive pill Yeztugo and the single-tablet treatment Dovato from its Affordable Care Act formularies, Lookout reported. The notices arrived during open enrollment, after many employers had already locked in 2027 coverage. By Friday morning, the insurer told Lookout it would restore all HIV medications to its ACA plans for next year.

The about-face came after patients showed clinic staff the cancellation letters. “We’re turning around and telling folks the care that has been life-giving for you and has allowed you to thrive is being taken away from you,” said Jessyca Leach, CEO of Prisma Community Care. “This makes me feel like we’re back in the ’90s.”

The episode matters because Maricopa County is one of 48 jurisdictions the CDC has prioritized for ending the HIV epidemic, yet new diagnoses there jumped 34 percent between 2020 and 2024, rising from 474 to 635 cases, according to the county Department of Public Health. Statewide, new diagnoses climbed from 776 in 2021 to 904 in 2024.

AZ Blue Reverses Plan to Drop Two HIV Drugs From 2027 ACA Plans After Questions
Photo: lookoutnews.org

The drugs at stake

Yeztugo is a preventive pill taken alongside a long-acting injection; together they are more than 99 percent effective at stopping HIV transmission. Dovato is a once-daily, two-drug treatment regimen. Both are newer options with fewer side effects than older regimens. AZ Blue initially said it would keep only Biktarvy, another single-tablet treatment, on the 2027 formulary.

Even a forced switch to Biktarvy carries risk. “Forcing a patient to switch regimens can lead to their HIV being unmanaged and potential complications from starting a new medication with new side effects,” said Emily Snyder, an HIV specialist and nurse practitioner at Prisma.

“If their viral load becomes detectable, that puts them at risk of developing AIDS and becoming at risk of opportunistic infections.” Gaps as short as one week can let the virus rebound and develop resistance, she added.

Employers finalized plans before drug removal notice

The letters went out as recently as October 30, Lookout found. Many employers finalize health-plan selections in September and October, meaning workers may have already committed to 2027 coverage before learning their drugs were slated for removal.

For people buying their own plans on the ACA marketplace, December 15 is the deadline for coverage starting January 1, according to the U.S. Department of Health and Human Services. Open enrollment runs through January 15, but plans chosen after December 15 generally do not take effect until February — leaving a potential month without coverage for patients scrambling to file exceptions or switch drugs.

Stacey Jay Cavaliere, executive director of Aunt Rita’s Foundation, called the timing “concerning.” “That could potentially limit their ability to explore alternative coverage before these changes take place,” Cavaliere told Lookout.

Mississippi plan expanded coverage after federal complaint

Arizona is not the only state where a Blue Cross Blue Shield plan has drawn scrutiny over HIV drug coverage. In June, Mississippi Today reported that Blue Cross and Blue Shield of Mississippi expanded coverage for the prevention pills Descovy and the injectable Apretude only after the HIV and Hepatitis Policy Institute filed a federal complaint alleging violations of coverage requirements that were expanded in 2024 to include long-acting prevention protocols.

Even after Friday’s reversal, the Institute said that AZ Blue still classifies two long-acting injectables — Yeztugo and the treatment Cabenuva — as medically unnecessary.

Leach warned that if one major insurer succeeds in narrowing formularies, others may follow. “What happens if they get this across and they’re allowed to do it, are other insurance companies going to look at doing the exact same thing?” she said.

Blue Cross Blue Shield of Arizona operates as one of 33 independent, locally managed companies within the Blue Cross Blue Shield Association. This federation was established in 1982 through the merger of two distinct organizations: the Blue Cross network, which originated in 1929 to cover hospital services, and the Blue Shield system, which began in 1939 to cover physicians’ services.

Today, these affiliated plans hold a significant role in the U.S. insurance market, collectively providing coverage to more than 115 million people as of 2022.

As of Friday, Prisma staff were informing patients that the medications would remain covered. The clinic employs four patient navigators and recently added two community health workers to manage coverage exceptions — labor that would have surged had the cuts stood.